Fortress Biotech, Inc. Quarterly Costs and Expenses in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Fortress Biotech, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2018 to Q2 2024.
  • Fortress Biotech, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $42.7M, a 36.8% decline year-over-year.
  • Fortress Biotech, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $180M, a 34.9% decline year-over-year.
  • Fortress Biotech, Inc. annual Costs and Expenses for 2023 was $227M, a 18.8% decline from 2022.
  • Fortress Biotech, Inc. annual Costs and Expenses for 2022 was $279M, a 8.54% increase from 2021.
  • Fortress Biotech, Inc. annual Costs and Expenses for 2021 was $257M, a 84% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $180M $42.7M -$24.8M -36.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $205M $49.6M -$21.7M -30.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $227M $39.6M -$31.5M -44.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $258M $48.5M -$18.8M -27.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $277M $67.5M -$2.32M -3.33% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $279M $71.3M +$101K +0.14% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $279M $71M -$13M -15.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $292M $67.3M -$3.75M -5.28% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $296M $69.8M +$9.11M +15% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $287M $71.2M +$29.6M +71.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $257M $84M +$46M +121% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $211M $71M +$38.5M +118% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $173M $60.7M +$25.8M +74.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $147M $41.6M +$7.16M +20.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $140M $38.1M -$3.46M -8.33% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $143M $32.5M +$206K +0.64% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $143M $34.9M +$313K +0.91% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $143M $34.4M -$4.64M -11.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $147M $41.5M Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 $32.3M -$1.07M -3.19% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $34.5M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $39.1M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 $33.4M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.